Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
最近の投稿
- 1
Spots To Go Birdwatching All over the Planet - 2The Hybrid Volkswagen ID. ERA 9X Will Become the Brand’s New Flagship in China
- 3A throat bone settles it - Nanotyrannus was not a juvenile T. rex
- 4Vote In favor of Your Favored Kind Of Bites
- 5Watch Chinese astronauts enjoy '1st ever space BBQ' from Tiangong's brand-new oven (video)
- Vote in favor of Your Number one Smartwatch: Exactness and Style Matter
- From Certificate to Dollars: College Majors with Extraordinary Monetary Prizes
- Public Parks in the USA
- Could the Star of Bethlehem have actually been a comet?
- Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- Figure out How to Reveal Stowed away Open Record Rewards
- Instructions to Plan for Your Teeth Substitution Methodology
- Woman shocked to welcome baby after experiencing stomach pain on Christmas
- Two reportedly killed as Israel attacks Hezbollah targets in Lebanon
